PSEN1 and Alzheimer disease: Previous studies have reported that genetic disruption of PERK in AD mouse models such as APP/PS1 and 5XFAD mice can rescue AD-associated phenotypes, suggesting that inhibiting the upstream kinase of eIF2α may be beneficial to AD [9, 10, 13].